Stay updated on Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.

Latest updates to the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedFooter revision label updated to Revision: v3.3.4; the previous Revision: v3.3.3 label was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedIntroduced a consolidated 'Locations' section listing study sites by state (California, Kentucky, Louisiana, Minnesota, New York, North Carolina, Pennsylvania, South Carolina, Texas, Washington, West Virginia, Wisconsin) and removed the separate per-state location subsections. Page version updated to v3.3.3.SummaryDifference1%

- Check60 days agoChange DetectedThe Publications section now states that items are automatically filled from PubMed, and the revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedThe government funding status banner, including references to cc.nih.gov and opm.gov, has been removed from the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedNo significant changes to the study details were detected; the differences appear to be UI/layout adjustments without affecting the study design or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check110 days agoChange DetectedSignificant: there is an updated operating-status notice and a new version (v3.2.0) replacing v3.1.0. This informs users about potential delays, open status of NIH Clinical Center, and directs to cc.nih.gov and opm.gov for updates.SummaryDifference3%

Stay in the know with updates to Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.